✦ LIBER ✦

CSF α-synuclein, tau, and amyloid β in Parkinson's disease – Authors' reply

✍ Scribed by Brit Mollenhauer; Walter J Schulz-Schaeffer; Michael G Schlossmacher

Book ID: 114409858
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 45 KB
Volume: 10
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(11)70161-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CSF α-synuclein, tau, and amyloid β in P

CSF α-synuclein, tau, and amyloid β in Parkinson's disease

✍ Min Shi; Jing Zhang 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 36 KB

Interaction of α-synuclein and tau genot

Interaction of α-synuclein and tau genotypes in Parkinson's disease

✍ Catherine E. Mamah; Timothy G. Lesnick; Sarah J. Lincoln; Kari J. Strain; Mariza 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

Tau and α-synuclein in susceptibility to

Tau and α-synuclein in susceptibility to, and dementia in, Parkinson's disease

✍ An Goris; Caroline H. Williams-Gray; Graeme R. Clark; Thomas Foltynie; Simon J. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

Reply: Expression of α-Synuclein mRNA in

Reply: Expression of α-Synuclein mRNA in Parkinson's disease

✍ Ornit Chiba-Falek; Grisel J. Lopez; Robert L. Nussbaum 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Cerebrospinal fluid Tau/α-synuclein rati

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

✍ Lucilla Parnetti; Davide Chiasserini; Gianni Bellomo; David Giannandrea; Claudia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

## Abstract Although alpha‐synuclein is the main constituent of Lewy bodies, cerebrospinal fluid determination on its own does not seem fundamental for the diagnosis of synucleinopathies. We evaluated whether the combination of classical biomarkers, Aβ~1–42~, total tau, phosphorylated tau, and α‐sy

CSF Aβ42 and tau in Parkinson's disease

CSF Aβ42 and tau in Parkinson's disease with cognitive impairment

✍ Thomas J. Montine; Min Shi; Joseph F. Quinn; Elaine R. Peskind; Suzanne Craft; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

## Abstract We tested the hypothesis that the CSF biomarker signature associated with Alzheimer's disease (AD) is present in a subset of individuals with Parkinson's disease and Dementia (PD‐D) or with PD and Cognitive Impairment, Not Dementia (PD‐CIND). We quantified CSF Aβ~42~, total tau (T‐tau),